Filing Details
- Accession Number:
- 0001209191-12-049959
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-18 18:38:22
- Reporting Period:
- 2012-10-16
- Filing Date:
- 2012-10-18
- Accepted Time:
- 2012-10-18 18:38:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Evp Of R&D & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-10-16 | 334 | $34.12 | 348,434 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-10-16 | 3,097 | $35.08 | 345,337 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-10-16 | 1,569 | $35.83 | 343,768 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 8, 2012.
- Represents weighted average sale price. Actual sale prices ranged from $33.58 to $34.44.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on each of February 15, 2013 and 2014, and the 1/3 of the shares that vested on February 15, 2012, net of withholding.
- Includes 5,700 restricted stock units awarded February 5, 2012 which vest as to 1/3 of the shares on February 15, 2013, 1/3 of the shares on February 15, 2014 and 1/3 of the shares on February 15, 2015.
- Represents weighted average sale price. Actual sale prices ranged from $34.63 to $35.59.
- Represents weighted average sale price. Actual sale prices ranged from $35.72 to $35.99.
Billionaire Hedge Funds
